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We have generated a mouse carrying the human
G551D mutation in the cystic fibrosis transmembrane
conductance regulator gene (CFTR) by a one-step gene
targeting procedure. These mutant mice show cystic
fibrosis pathology but have a reduced risk of fatal
intestinal blockage compared with 'null' mutants, in
keeping with the reduced incidence of meconium ileus
in G551D patients. The G551D mutant mice show
greatly reduced CFTR-related chloride transport, dis-
playing activity intermediate between that of cftYmlUNC
replacement ('null') and cftrlHGU insertional (residual
activity) mutants and equivalent to -4% of wild-type
CFTR activity. The long-term survival of these animals
should provide an excellent model with which to study
cystic fibrosis, and they illustrate the value of mouse
models carrying relevant mutations for examining
genotype-phenotype correlations.
Keywords: animal models/cystic fibrosis/gene targeting/
genotype-phenotype correlations/meconium ileus
Introduction
An important goal in the field of human genetics is to
understand the relationship between gene function and
disease pathophysiology. Cystic fibrosis (CF) is the most
common lethal genetic disorder in the Caucasian popula-
tion, and is caused by mutations in the cystic fibrosis
transmembrane conductance regulator (CFTR). We, and
others, have produced mouse models for CF in which
mutations have been introduced into the murine CFTR
gene (Cftr) by homologous recombination in embryonal
stem (ES) cells (reviewed in Dorin et al., 1994a). These
animals demonstrate both the characteristic CF chloride
defect and intestinal pathology typical of this disease.
They have also proved useful in pre-clinical studies of
CFTR gene transfer using correction of the chloride
transport deficit as the primary measure of efficacy (Alton
et al., 1993; Hyde et al., 1993; Grubb et al., 1994).
However, the available models carry grossly disrupted
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alleles, resulting either in no CFTR protein, exemplified
by the 'null' cftr-In'UNCgene replacement event (Snouwaert
et al., 1992), or very low levels of normal protein, as in
the case of the Cftr-nlHGU gene insertion event (Dorin et al.,
1994b). In contrast, the majority of CF patients carry
subtle mutations which result in the production of a
dysfunctional mutant protein (Tsui, 1992). The effect of
ectopic expression of normal CFTR on a mutant CFTR
background is unknown and it may, therefore, be important
and instructive to carry out such gene transfer studies in
a mouse engineered to carry a mutant form of CFTR
equivalent to that which occurs in CF subjects.
G551D is one of the most ancient and common CF
mutations, with a world-wide frequency averaging 3% but
found at higher frequencies in populations of Celtic descent
(Hamosh et al., 1992). In humans, G55 lD CFTR protein is
processed normally but produces cAMP-regulated chloride
channels showing markedly reduced function (Class III
mutation) (Welsh and Smith, 1993). A key aspect of this
mutation is the 3-fold reduction in the incidence of
meconium ileus (neonatal intestinal blockage) in CF
patients carrying the G55 1D mutation compared with
patients homozygous for the most common CFTR muta-
tion, AF508 (Hamosh et al., 1992). We have used a single-
step targeting strategy to introduce the human missense
mutation G551D into mice, allowing us to determine
whether this protective effect is substantiated across
species and allowing for the first time the examination of
CF genotype-phenotype correlations in the laboratory.
We have examined the histological features and deter-
mined the electrophysiological responses of the G55iD
mutant mice, and show that the phenotype is intermediate
between that of existing cfti-'/IUNc replacement ('null')
and cft,,IHGU insertional (residual activity) mutant mice.
Importantly, intestinal blockage is reduced and survival
increased in comparison with the 'null' cftenlUNC mutant
mouse, mimicking the mild intestinal phenotype of G55 ID
patients. In man, only a small number of CF phenotype-
genotype correlations have been established (Hamosh and
Cutting, 1993). This study indicates, therefore, how mice
carrying relevant mutations may be used to test phenotype-
genotype correlations which are difficult to establish
clinically. These may be difficult to establish either because
the numbers of patients with particular mutations are
low or because any intrinsic effects are submerged by
environmental or epigenetic factors.
Results
Generation of G551D mice
RI ES cells were electroporated with the linearized target-
ing construct (Figure IA) which carries both the G55iD
mutation and neomycin-selectable marker sequences. To
minimize disruption of the transcription of the targeted
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Fig. 1. Generation of mice carrying the G55 I D mutation. (A) Targeting of exon 11I to produce the 6551I D mutation; the genomic region of the Cftr
gene cloned is shown at the top, exons 11, 1 Ib, 12 and 13 are represented by filled boxes; EcoRI (E), HindIII (H), Kpnl (K), Xhol (X) and Xbal
(Xb) restriction enzyme sites are indicated. The targeting construct shown below contains a 6.3 kb Xbal genomic fragment into which two pgk-neo
expression cassettes have been inserted, both in the same orientation as that of the C'ftr gene. A HSV-TK expression cassette (hatched box) is
situated at the 3' end, together with vector sequences (not shown). The structure of the genomic locus following targeting is shown at the bottom.
The sizes of novel Sacl, S and BstXl, B, restriction enzyme fragments identified by an external 3' probe are indicated. (B) Representative Southern
blot performed on ES cell DNA with the probe indicated in (A); targeted colony (lanes and 2), non-targeted colony (lanes 3 and 4) digested with
Sacl (lanes I and 3) and BstXI (lanes 2 and 4). The sizes of the novel restriction enzyme fragments generated by the tar-geting event are indicated at
the left of the panel. (C) The absence of novel splice variants in 655 ID animals is shown by RT-PCR performed on RNA prepared from wild-type
(lane 1). ±/cftrG55ID (lane 2) and cftrG55II/ lcftrl;55II)1 mice (lanes 3-6). Lanes 1-3, small intestine; lane 4, kidney; lane 5, lung; lane 6, testis; lane 7,
no RNA control. (D) Quantitation of 6551 D transcripts by RT-PCR. To distinguish wild-type and 6551lD transcripts, all products have been digested
with Bsal. Lanes I and 2 are reactions performed on tissues from a wild-type mouse, lanes 3-5 are reactions carried out on RNA from a ±/cftrG55SID
animal. Lanes 1 and 3, testis RNA; lanes 2 and 4. kidney RNA; lane 5, small intestine RNA. The identity of the bands detected is shown at the right
of the panel.
allele, selectable marker sequences were positioned
adjacent to exon 1lb which is skipped in somatic CFTR
transcripts (Delaney et al., 1993). Targeting of the Cftr
locus in ES cells by homologous recombination was
identified by Southern blot analysis (Figure I B). This
occurred in 37 of 96 ES colonies obtained under positive/
negative selection. Fifteen of 18 targeted colonies tested
by allele-specific PCR retained the G551D allele. Five of
these lines were used to generate chimaeric animals, and
two males from independent cell lines showed germ-line
transmission. Approximately half of the progeny of the
two transmitting males were heterozygous for the G551D
allele, as determined by allele-specific PCR (data not
shown). We have designated this allele cftrTgHmIG55sD but
will refer to it in this manuscript as cftrGS5ID. These
heterozygous animals were inter-crossed to produce wild-
type (+/+), heterozygous (+/cftrG551D) and homozygous
mutant (cftrGS/DIcftrGSSID) offspring. In agreement with
the expected ratio of 1:2:1, in 123 animals genotyped
from these crosses, 23% were +/+, 48% were +/cftrG55ID
and 29% were cftrG55D/cftrG55ID. RT-PCR carried out on
RNA prepared from a variety of tissues from heterozygous
and homozygous animals indicated that selectable marker
sequences retained in the targeted allele were not being
incorporated as novel additional exons into CFTR tran-
scripts (Figure IC). Semi-quantitative RT-PCR indicated
that the level of transcription of the G551D allele in a
variety of tissues was ~53% of that of the wild-type allele
(Figure ID).
Intestinal obstruction is responsible for perinatal
lethality and is reduced in G551D mutant mice
compared with cftrJnlUNC ('null') mice
In crosses between heterozygous animals, cftrG55DI
cftrG55D offspring were runted and between 50 and 70%
of the weight of normal siblings. In matings maintained
in specific pathogen-free conditions, ~33% of homozygous
animals (46/141) died from intestinal obstruction before
35 days after birth (Figure 2). The site of intestinal
obstruction in most animals, regardless of age, was just
956
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Fig. 2. Viability of cftr('5511/(ftr(;5511' animals.
animals reared in specific pathogen-free conditi(
cftr(;551D/cftr(S55D n = 141, +/+ and +/cftrG'5
distal or proximal to the caecum, and
appeared to be peritonitis due to intesi
To compare directly the relative sun
ing different Cftr mutant alleles, anim;
housed in the same facility. The survi
8% (2/27) for the CftrlnIUNC animals at
the cftrrG55ID animals. Survival of cftr)
93% as previously determined (Dorin
reason for the reduction in survival of
common facility is uncertain, but mos
transfer from a specific pathogen-free ti
facility and a concomitant change of foc
of the lung, crenation of the airway epithelia and epithelial
hyperplasia. Using these criteria, no difference could
be detected between homozygous animals and control
siblings. No abnormalities were detected in the epithelia
of the trachea or pharynx of nine cftrG55 !)cftrG55ID
animals, but three showed inspissated eosinophilic material
W
,M.M.M.-Onru.'" in the lumen of the pharyngeal submucosal glands (Figure
4A and B).
In three of seven mutant animals suffering from intes-
tinal obstruction, the gallbladder appeared black and
enlarged. Abnormalities were also evident in a number of
ID * healthy mutant animals, and included gallbladders which
were black, enlarged or reduced in size. Five of nine
gallbladders from cftrGSSlD/cftrG55D animals showed the
presence of large numbers of polymorphonuclear cells,
particularly eosinophils, in the gallbladder wall. In two of
these animals, the gallbladder wall had an extremely
vacuolated appearance in addition to the presence of
inflammatory cells (Figure 4C and D). Abnormalities were
40 50 60 also evident in the biliary tree of the liver. In three of 15
animals there was hyperplasia of the bile duct epithelia
The survival of and in one of these animals there were bile pigments in
ons is shown. the hepatocytes. Another of these three apparently healthy51D n = 67. mutant animals showed focal biliary cirrhosis. In the area
of focal cirrhosis, the biliary ducts were completely absent
and were replaced by a fibrotic stroma and an inflammatory
the cause of death infiltrate characterized by large numbers of eosinophils
tinal perforation. (Figure 4E and F). Elsewhere in the liver, other than
vival of mice carry- some bile ducts showing hyperplasia, the tissue was
ails were reared and unremarkable.
ival at 35 days was Salivary gland defects have been reported in CF indi-
nd 27% (12/44) for viduals and other CF mouse models (Ratcliff et al., 1993).
nlIHGU mutants was In two out of 10 GS51D animals examined, the gland
et al., 1994b). The appeared hypercellular due to the serous cells having lost
G551D mice in the their vacuolated appearance (Figure 4G and H). The
,t likely reflects the reproductive tract of five female and four male G55 ID
o a standard animal animals appeared normal in comparison with control
)d and bedding. The animals.
survival of the G55 ID mice was nevertheless significantly
higher than for cftrn,'UNC mutants (P<0.0S).
Histopathological abnormalities in G551D animals
Histological examination of the intestinal tract of 15
cftrG5DlcftrGS55D adult animals of various ages revealed
abnormalities in all mutant mice when compared with
control (+fcftrG55I1D or +/+) siblings, regardless of intes-
tinal obstruction. The small intestines of mutant animals
showing obstruction were grossly abnormal, with loss of
the villi and the accumulation of necrotic and faecal
material in the lumen (Figure 3B). The most characteristic
abnormality found in all of the apparently healthy mutant
mice examined was the presence of eosinophilic concre-
tions in the crypts of Lieberkuhn. This results in the
dilation of some crypts, particularly in the jejunum (Figure
3C and D). The colon of some animals also showed
dilated mucus glands (data not shown).
In keeping with previous studies of the cftr*llnUNC
(Snouwaert et al., 1992) and CftrPnIHGU mutant mice (Dorin
et al., 1992), no difference in the appearance of the acinar
or epithelial cells of the pancreas was detected between
cftrG55D/cftrGS5SD animals and control siblings. The lungs
of 10 animals were also examined histologically and
scored for cellularity of the lung parenchyma, expansion
Electrophysiological responses of the
cftrG55lD/cftrG55lD mice
In comparison with wild-type litter mates, sodium-related
measurements [baseline potential difference (PD) and
response to amiloride] were significantly (P<0.001)
increased in the nasal epithelium of cftrG55ID/cftrG55ID
mice in vivo (Figure SA and B). The baseline PD profile
closely resembles that seen in man, with a gradual increase
in PD within the nasal cavity. Furthermore, the maximal
value was reached at a greater distance from the external
nares in the mutant mice, similar to the case in CF
subjects. Subsequent perfusion with the cAMP-related
agonist forskolin produced no response in the mutant
mice; typically a depolarization was seen (Figure 5C).
Finally, perfusion with ATP produced no significant differ-
ence between the calcium-related chloride secretion of the
two genotypes (Figure 5D). In the trachea, in vitro
measurements of baseline short circuit current (ISC) or
response to amiloride showed no significant difference
between genotypes (Figure 5 legend), although the GSS 1 D
mutant mice tended to have reduced values for both
responses. Subsequent addition of forskolin produced a
significantly (P<0.01) reduced response in the mutant
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Fig. 3. Gut pathology of cftrGS55D/cftrGSSID animals. (A) and (C) are tissues dissected from +/+ or +/cftrG551D animals; (B) and (D) are from
G551D homozygotes. (A) and (B) are stained with PAS; (C) and (D) are stained with haemotoxylin and eosin. (A) and (B) are transverse sections of
the small intestine. (C) and (D) are transverse sections of the wall of the jejunum; in the cftrG551D/cftrG55D animal (D), apparently healthy when
sacrificed, eosinophilic concretions are present in the crypts of Lieberkuhn (arrowed). For each tissue, control and cftrG551D/cftrG551D samples are
shown at the same magnification. Scale bar: (A) and (B), 450 gm; (C) and (D), 50 gm.
mice (Figure SE), whilst ATP responses were significantly
(P<0.05) greater in the mutant mice (Figure 5E legend).
Throughout the intestinal tract, whether studied in vitro
(jejunum and caecum) or in vivo (rectum), both baseline
values and the response to forskolin were significantly
(P<0.001) reduced (Figure 6). We, and others, have
demonstrated previously that the response of wild-type
mice to forskolin principally relates to chloride secretion
(Alton et al., 1993). This was confirmed in the present
study by the subsequent addition of bumetanide (Figure
6). We also attempted to assess the effect of ionomycin
(5 ,uM) added at the peak of the forskolin response. In
both genotypes, this addition produced variable small
changes, in keeping with CFTR acting as the principal
chloride channel in the intestinal tract. Thus, in all tissues
studied, the animals are characterized by a marked reduc-
tion in CFTR-related bioelectric responses.
The most frequent site of intestinal obstruction for
cftrGS51D/cftrG55D animals was near the caecum, and the
apparent protection against intestinal obstruction relative
to cftenIUNC/cftrenIuNc 'null' mutant mice might result from
residual CFTR-related chloride conductance in this region.
For comparison, we therefore also measured in vitro
forskolin responses in cften1UNc1cft,nJuNC mice. In these
animals, forskolin responses in the caecum were small,
variable and frequently depolarizing, equivalent in magni-
tude to ~0.5% (0.8) of wild-type values. In contrast,
cftrG5DlcftrGCS5D animals show a residual caecal forskolin
response (Figure 6B) significantly (P<O.05) greater than
those of cfte IUNc/cfteIuNc mice equivalent to ~4.9% (1.3)
of wild-type values. In the jejunum, forskolin responses in
cftrGSSIDlcftrG55D mice also tended to be greater than
those in cftelIuNc/cftenIuNc mice equivalent to ~2.9%
(3.3) of wild-type values.
Discussion
We have used a single-step gene targeting procedure to
produce mice carrying the equivalent of the common
human mutation G551D by placing the marker sequences
necessary to select for homologous recombination events
adjacent to an exon which is skipped in somatic cells. In
common with existing CFTR 'null' mouse mutants, G55 1D
mutant mice display runting, intestinal obstruction,
gallbladder abnormalities and alterations in serous and
mucous glands, and show an absence of frank pathology
in the lungs, pancreas and reproductive tract. The patho-
logical changes seen in the liver and biliary tract are
similar to the focal biliary cirrhosis seen in 5% of CF
patients (Park and Grand, 1991) and are of specific interest
as they have not been reported previously in other CF
mouse models. This may reflect the combined effect of
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Fig. 4. Pathology of G551D animals in epithelial lined tissues. (A), (C), (E) and (G) are tissues from +/+ or +/cftrG551D animals: (B). (D), (F) and (H) from
cftrG55IDIcftrG55) animals. All animals were apparently healthy when sacrificed. (A) and (B) Mucosal glands from behind the pharynx. The cftrG55 1DI
cftrG'S55ID animal (B) has an accumulation of eosinophilic material in the acinar lumen (arrowed). (C) and (D) Sections of the gallbladder: the enlarged
gallbladder of a cftrG55iIDCftrCSI5D animal (D), apparently healthy when sacrificed, shows a highly vacuolated epithelium [cf. wild-type sibling (C)] and
evidence of an inflammatory infiltrate (arrowed). (E) and (F) Liver: the cftrGS511IcftrGS5D animal (F) show's a focal inflammatory infiltrate with an apparent
absence of bile ducts when compared with a control sibling (E). (G) and (H) Submaxillary salivary gland; the serous cells of the cftr(55SD/CftrG55Il) animal
(H) have lost some of their vacuolar appearance, as a result the gland appears hypercellular compared with a sibling control (G). For each tissue control and
cftirG55lDhftrGSSIlD samples are shown at the same magnification. Scale bar; (A). (B), (E) and (F) 50 jm; (C) and (D) 20 ,um, (G) and (H) 100 gm.
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Fig. 5. Measurement of bioelectric responses in the airways of G55 ID mice. (A)-(D) In vivo recordings from the nasal epithelium; (E) in vitrorecording from the tracheal epithelium. (A) Baseline nasal potential difference (PD) in cftrG55D/cftrGSI55D mice (n = 7) in comparison with wild-typemice (n = 10). Comparison of maximal PD in cftr(55SIlcftr G551D versus +/+, P<0.001. (B) The response to perfusion with amiloride (100 MM).(C) The response to forskolin (10 gM) in a low Cl- (6 mM) solution. (D) The response to perfusion with ATP (100 ,uM) in a low Cl- (6 mM)solution. (E) The response to forskolin (10 gM) in cftrG551D1cftrG551D mice (n = 7) and +/+ mice (n = 41). Baseline values were: cftrG551D/cftrG551D 31.6 jiA/cm2 (5.3); +/+ 42.0 ,uA/cm2 (3.8). Responses to amiloride were: cftr6;551D-28.8 gA/cm2 (8.6); +/+ -30.7 gA/cm2 (3.0).Responses to ATP were: cftrG551D/cftrGS55D 111.4 jiA/cm2 (14.4); +/+ 70.4 gA/cm2 (8.4), P<0.05. In each of the above, error bars indicate standarderror of the mean (SEM). *** P<0.01. Hatched bars = +/+, speckled bars = cftr(GSSD/cftrGSSI.
the increased longevity of these mice compared with
cftrlIUNC 'null' mutants and reduced residual CFTR-
related chloride transport function compared with
cftenIHGU mutants which have -10% wild-type CFTR
mRNA (Dorin et al., 1994b). Further study is warranted
to distinguish between a specific effect of the G551D
mutation and a direct effect of limited CFTR function.
G551D CFTR is known to reach the apical membrane(Class III CFTR mutation), but probably demonstrates
reduced residence time at this site (Prince et al., 1994).
Increases in cAMP levels inhibit the normal cycling ofCFTR between the apical surface and an endocytic pool,but this inhibition does not occur with the G55 ID mutation.
Furthermore, G551D demonstrates reduced nucleotide
binding to the first nucleotide binding fold in which the
mutation is localized (Logan et al., 1994). Both thesefactors are likely to play a part in the markedly reducedfunction demonstrated here in the mutant mice and also
reported in studies in cultured cells (Gregory et al., 1991;Yang et al., 1993) and Xenopus oocytes overexpressing
960
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Fig. 6. Measurements of bioelectric responses in the intestine of
cftr(i55Il)/cftrG55I) animals. (A) Jejunum studied in vitro, +I+ n = 10;
Cftr(;551)1/cftrG55II) n = 7. (B) Caecum studied in vitro, +I+ n = 11;
cftrG551lDcftrGSSI) n = 7. (C) Rectum studied in vivo +/+ n = 9;
cftrG55I)lcftrG55I) n = 7. Conductance values were, jejunum: +/+
14.6 mS/cm2 (1.0), cftr(5511)/cftrG551) 19.0 mS/cm2 (6.1); caecum:
+/+ 16.9 mS/cm2 (1.7), cftrG'551/)1cftrG551D) 14.0 mS/cm2 (1.3); all
conductance comparisons P = NS. In each figure, error bars indicate
SEM. ***P<0.001. Hatched bars = ±/+, speckled bars = cftrG5511)/
cftr(551D.
the mutant protein (Drumm et al., 1991). In the latter
in vitro studies, G55lD demonstrated -25-35% of the
function produced by wild-type CFTR, in apparent marked
contrast with our findings of an average value of 4% of
wild-type responses in the mutant mice. The difference is
most likely explained by the very different experimental
systems studied and the inclusion of 3-isobutyl-l-methyl-
xanthine (IBMX) in the stimulant cocktail. Phospho-
diesterase inhibitors such as IBMX have been shown
recently to activate G551D channels (Becq et al., 1994),
and suggest a therapeutic approach which may be tested
in the cftrGSSID mice.
Reduced cAMP, but not calcium-mediated chloride
transport, was observed in the airways of the G55iD
mutants, as predicted from previous studies of CFTR
function. We also demonstrate in the mouse that the
G55 ID mutation increases sodium transport in the airways.
To our knowledge, this has only been reported previously
for CF subjects with either Class I 'null' mutations (and
a complete absence of cellular CFTR) or Class II mutants,
such as AF508 (in which the mutant protein is localized
to the cytoplasm). Our results suggest that fully functional
CFTR localized to the apical membrane appears to be
necessary to prevent an increase in sodium absorption in
the airways.
We measured a small, but significantly elevated response
to forskolin in the caecum of G55 1D mice compared with
'null' mutants which had a marked effect on survival. As
many as 67% of G55 lD mutant mice survived to 35 days
when housed under specific pathogen-free conditions.
Under conventional animal housing, survival was reduced
to 27%, but this was still significantly higher than for
complete 'null' mutants (8% survival; P<0.05). The
improved survival of cftrGSSD/cftrG55D animals versus
cfteInlUNC/cftemlUNC mice is in accord with the clinical
picture where CF patients bearing the G551D allele are
indistinguishable in all respects from AF508 homozygotes
except for a 3-fold decrease in risk of meconium ileus
(Hamosh et al., 1992). This genotype-phenotype correla-
tion is therefore substantiated across species, and the
residual bioelectric responses in G551D animals probably
explain these findings. The production of these G55iD
mice illustrates how mouse models carrying clinically
relevant mutations may be of use in establishing mechan-
isms which underlie genotype-phenotype correlations.
The survival of the cftrGSSD homozygous mice is clearly
improved over that for the cfteIUNC homozygotes, despite
only a very low level of residual cAMP-mediated chloride
conductance. This provides evidence for a phenotypic
effect accruing from only a modest level of normal CFTR
chloride channel function (in the caecum equivalent to
-5% of wild-type function). This is encouraging with
respect to both gene therapy and pharmacological-based
strategies for the treatment of CF. Our results also comple-
ment those of Zhou et al. (1994) who recently reported
that transgenic expression of the human CFTR transgene
driven by the FABP promoter, active in intestinal villus
cells, restored ~30% of the cAMP-mediated chloride
conductance, sufficient to substantially rescue the cft)nIUNC
mutant strain from fatal intestinal disease.
The resulting good survival of the G551D mice means
they provide an excellent model with which to study other
aspects of CF pathogenesis, for example involving the
lung and liver. We have recently shown that cft,nIHGU
mice develop lung disease on exposure to CF-related
pathogens (Davidson et al., 1995). It will be of interest
to establish whether the G551D mice, which have less
residual CFTR function than the CfteJ)HGU mice, develop
more severe lung disease that might recapitulate the
961
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chronic infection found in patients. These animals are the
first CF mice to be produced to carry a Class III mutation,
which occur in a significant number of CF patients. In
contrast to the most common CFTR mutation (AF508),
Class III mutations result in CFTR which is able to reach
the apical membrane. These mice will therefore also be
of value in testing treatment strategies that may only be
applicable to this type of mutation, for example activation
by pharmacological agents which alter CFTR regulation.
Materials and methods
Construction of the G551D targeting vector
A phage clone was isolated from an 129-Sv genomic library using a
primer homologous to exon 11 sequences (nt 1721-1742) and contained
exons 11, lb, 12 and 13. The G55lD mutation was introduced into
exon 11 by PCR with Vent polymerase (New England Biolabs) using
the primer (5'-CACTG AGTGG AGACC AGCGT GC-3'). Mutagenized
clones were checked for PCR errors in coding regions, and a fragment
containing exon 11 and 12 was used to replace the equivalent wild-type
sequences in a subclone containing 6.3 kb of Cftr genomic DNA. A
HSV-TK cassette was inserted at the 3' end of the insert (Mansour et al.,
1988). Two pgk-neo cassettes (Tybulewicz et al., 1991), as used in other
Cftr replacement constructs (Koller et al., 1991), were inserted 8 bp
downstream of exon II b.
Production of targeted lines and mutant mice
RI ES cells were maintained and selected on primary embryonic
fibroblasts (Wurst and Joyner, 1993) with leukaemia inhibitory factor
(LIF) added to the media at 1000 U/ml. Chimaeric animals were
produced by the aggregation method essentially as described for tetraploid
aggregation by Nagy and Rossant (1993), except that a clump of 10-15
ES cells was placed in a well with a single CD-1 8 cell morula.
Phenotype analysis of G55 1D mice was carried out on animals maintained
in specific pathogen-free conditions on wood shaving bedding and
standard rodent food (Norco Cooperative Ltd).
Allele-specific PCR
Amplification of DNA prepared from ES colonies or tail-tips for
genotyping was carried out using the primers (5'-GACAT CACCA
AGTTT GCAGA ACAAG-3') and (5'-GTATA AAGCT TACCG
GGTGT GGTG-3') and a thermal profile of 95°C 30 s, 67°C 45 s, 72°C
I min for 35 cycles. This primer pair produces a fragment of -640 bp
extending from the first nucleotide of exon 11 to 13 bp downstream of
exon llb and, in wild-type DNA, has a single BsaI site 83 bp from the
3' end. The mutagenesis of codon 551 results in the introduction of an
additional BsaI site such that PCR products from wild-type and cftrG51D
alleles differ in length following digestion with BsaI. Semi-quantitative
RT-PCR of G551D transcripts was performed essentially as previously
described (Delaney et al., 1993). Products were quantitated by the
inclusion of 1 tCi of [32P]ATP in the PCR reaction. The primers used
extend from exon 7 to exon 13 and were X7F2 (5'-GCCGT ACAGA
TATGG TATGA TTC-3') and SDCF 4 (5'-AAACT GGTCA AAAGT
ATCAT ACC-3'). Reactions were terminated in the logarithmic phase
of amplification. RT-PCR products corresponding to G551D transcripts
can be distinguished from wild-type transcripts by the presence of a
single BsaI site.
Relative survival of the CFTR mutant mice
For the comparison of survival rates, animals were housed under
conventional animal house conditions on Corn cob bedding (R.S.Biotech)
and fed standard rodent food CRMX (Special Diet Services). CftrmlUNC
mutant mice (Snouwaert et al., 1992) were obtained from the Jackson
Laboratories, Bar Harbor.
Histology
Dissected tissues were fixed in ice-cold 4% phosphate-buffered formalde-
hyde, embedded in paraffin wax and 6 gtm sections were cut and stained
with haematoxylin and eosin and periodic acid Schiffs (PAS) reagent.
Liver and lung sections were examined with the genotype of the
animal coded.
Electrophysiological methodology
Mice (weight 15-53 g) were anaesthetized (tribromoethanol 0.2 ml/10 g
intraperitoneally) and a subcutaneous electrode inserted into a hind limb.
Both this and the exploring electrode were connected by Krebs-HEPES
of composition (mM): Na+ 140, Cl- 152, K+ 6, Ca2+ 2, Mg2+ 1,
glucose 10, HEPES 10 to a calomel electrode and, in turn, to a hand-
held computer connected to a pre-amplifier containing a low-pass signal
averaging filter with a time constant of 0.5 s. The offset of the electrodes
was recorded prior to measurements, and appropriate corrections made.
Buccal PD was used to validate the integrity of the circuit, acceptable
values ranging from -10 to -17 mV. Rectal PD was measured using a
double-lumen tube of outer diameter I mm, inserted to a distance of
-15 mm. Following the recording of stable values (+ 0.2 mV over
15 s), drugs were perfused at a rate of 40 jl/min through the second
lumen. Amiloride (100 ,uM) followed by forskolin (10 gM), each
dissolved in Krebs-HEPES, were administered. Following these measure-
ments, an opening was fashioned in the laryngeal cartilage and a tissue
plug inserted. A tracheotomy was then made at the junction of the larynx
and trachea. For nasal measurements, the exploring electrode consisted
of a fine double-lumen plastic tube (outer diameter 0.5 mm) advanced
into the left nasal cavity and the stable PD (+ 0.5 mV over 15 s)
recorded at -1 mm intervals up to 10 mm. For drug perfusion, the
exploring electrode was positioned 5 mm from the external nares. Drugs
were perfused through the second lumen in the sequence: amiloride
(100 tM in Krebs-HEPES), forskolin (10 ,uM) and ATP [100 ,uM, both
in low chloride (6 mM) HEPES-Krebs with gluconate substitution]. The
junctional potential between the normal bathing solution and the low-
chloride solution was ignored because of paired comparisons. It is
unlikely that the paracellular shunt is affected in CF airway epithelium
(Widdicombe et al., 1985).
Following in viva measurements, animals were sacrificed, the trachea,
and caecum dissected and placed in Krebs Henseleit solution of composi-
tion (mM): Na+ 145.0, Cl- 126.0, K+ 5.9, Ca2+ 2.5, Mg2+ 1.2, HCO3-
26.0, P042- 1.2, So42- 1.2, glucose 5.6. The small intestine was placed
in an equivalent solution, with the glucose replaced by equimolar
mannitol. All tissues were transported to the laboratory on ice and
mounted in Ussing chambers of aperture diameter 0.28 cm2 (jejunum
and caecum) or 0.03 cm2 (trachea). Two chambers were obtained from
each jejunum and caecum and one from the trachea. Values were
subsequently meaned to provide a single measurement for each animal.
Both mucosal and serosal surfaces of the tissues were bathed in Krebs
Henseleit solution at 37°C, pH 7.4, circulated by 95% 02/5% CO2, with
the exception of the jejunum, where glucose was replaced with equimolar
mannitol on the mucosal surface. Studies were performed under short-
circuit conditions. Prior to and at the peak/trough of each drug interven-
tion, a 2 IA pulse was passed to allow measurement of tissue conductance.
In the trachea, once stable values were attained, tissues were treated
sequentially with amiloride (100 gM), forskolin (10 ,uM) and ATP(100 gM). All drugs were added mucosally. In the jejunum, the sequence
of additions was forskolin (10 ,uM, serosally), ionomycin (5 gM,
bilaterally), bumetanide (100 gM, serosally), glucose (5.5 mM,
mucosally) and phloridzin (200 ,uM, mucosally). In the caecum, the
sequence of additions was forskolin (10 ,uM, serosally), ionomycin
(5 ,uM, bilaterally) and bumetanide (100 ,uM, serosally). Recordings
from all animals studied are included in the analyses, with the exception
of one animal (cftrl, IUNC/cftrI11IUNC) in which no measurements could
be obtained because of technical difficulties. All statistical comparisons
were made using the Mann-Whitney U test; the null hypothesis was
rejected at P<0.05.
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